title: CABG versus PCI in the treatment of diabetic patients affected by coronary artery disease.
abstract: Surgical coronary revascularization and percutaneous coronary intervention were demonstrated to be effective treatments for coronary artery disease. However, the optimal revascularization strategy remains unclear in certain patient subsets. The recently published Future Revascularization Evaluation in Patients with Diabetes Mellitus: Optimal Management of Multivessel Disease (FREEDOM) trial is a randomized study evaluating the use of CABG versus PCI in diabetic patients with multivessel coronary disease. The purpose of this study was to review the available literature based on randomized trials and observational studies in order to allow clinicians to make evidence-based decisions when treating diabetic patients with multivessel coronary disease. The current evidence suggests that CABG should remain the standard of care for this patient population.
authors.affiliation: Cardiac Surgery Unit, Department of Clinical and Experimental Medicine, University of Parma.
authors.forename: Francesco
authors.initials: F
authors.lastname: Nicolini
authors.forename: Andrea
authors.initials: A
authors.lastname: Agostinelli
authors.forename: Antonella
authors.initials: A
authors.lastname: Vezzani
authors.forename: Filippo
authors.initials: F
authors.lastname: Benassi
authors.forename: Tiziano
authors.initials: T
authors.lastname: Gherli
mesh_terms: D001026:Coronary Artery Bypass; D003324:Coronary Artery Disease / Q000601:surgery*; D003925:Diabetic Angiopathies / Q000601:surgery*; D006801:Humans; D062645:Percutaneous Coronary Intervention; D016032:Randomized Controlled Trials as Topic